Shanghai Zerun Biotechnology Co.,Ltd   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Shanghai Germany (2003)
Status: Acquired by Walvax Biotechnology Co., Ltd. (2012)

Organization Overview

First Clinical Trial
2012
NCT01548118
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Shanghai Zerun Biotechnology Co.,Ltd | Yuxi Zerun Biotechnology Co., Ltd.